Previous Article | Next Article 
Journal of Bacteriology, September 2001, p. 4985-4993, Vol. 183, No. 17
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.17.4985-4993.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
The Saccharomyces
cerevisiae Isw2p-Itc1p Complex Represses
INO1 Expression and Maintains Cell
Morphology
Minetaka
Sugiyama and
Jun-Ichi
Nikawa*
Department of Biochemical Engineering and
Science, Faculty of Computer Science and Systems Engineering,
Kyushu Institute of Technology, Iizuka, Fukuoka 820-8502, Japan
Received 5 March 2001/Accepted 13 June 2001
 |
ABSTRACT |
In the yeast Saccharomyces
cerevisiae, IRE1 encodes a bifunctional
protein with transmembrane kinase and endoribonuclease activities. HAC1 encodes a transcription factor
which has a basic leucine zipper domain. Both gene products play a
crucial role in the unfolded protein response. Mutants in which one of
these genes is defective also show the inositol-auxotrophic
(Ino
) phenotype, but the reason for this has not been
clear. To investigate the mechanism underlying the Ino
phenotype, we screened a multicopy suppressor gene which can suppress
the Ino
phenotype of the
hac1 strain.
We obtained a truncated form of the ITC1 gene that has a
defect in its 3' region. Although the truncated form of
ITC1 clearly suppressed the Ino
phenotype
of the
hac1 strain, the full-length
ITC1 had a moderate effect. The gene products of
ITC1 and ISW2 are known to constitute a
chromatin-remodeling complex (T. Tsukiyama, J. Palmer, C. C. Landel, J. Shiloach, and C. Wu, Genes Dev. 13:686-697, 1999). Surprisingly, the deletion of either ITC1 or
ISW2 in the
hac1 strain circumvented
the inositol requirement and caused derepression of INO1
even under repression conditions, i.e., in inositol-containing medium.
These data indicate that the Isw2p-Itc1p complex usually represses
INO1 expression and that overexpression of the truncated form of ITC1 functions in a dominant negative manner in
INO1 repression. It is conceivable that the repressor
function of this complex is regulated by the C-terminal region of Itc1p.
 |
INTRODUCTION |
It is well known that the
accumulation of an unfolded protein in the endoplasmic reticulum (ER)
initiates the unfolded protein response (UPR). The UPR induces the
transcriptional upregulation of multiple ER resident proteins involved
in protein folding (for reviews, see references 20,
23, and 44). BiP/GRP78 is an abundant protein
residing in the ER and essential for protein folding and protein
sorting as a molecular chaperone. The structure of BiP is highly
conserved from higher eukaryotes to yeast. In the yeast
Saccharomyces cerevisiae, the BiP protein is
encoded by KAR2. As in mammalian cells, the expression of
KAR2 in yeast cells is induced by a variety of treatments,
such as the addition of tunicamycin, which causes the accumulation of
the unfolded protein in the ER. IRE1 encodes a bifunctional
protein with transmembrane kinase and endoribonuclease activities that
transmits the stress signal from the ER to the nucleus. The
accumulation of the unfolded protein triggers Ire1p oligomerization,
thereby inducing autophosphorylation, resulting in subsequent
elicitation of the kinase and RNase activities. Activated Ire1p,
together with the tRNA ligase encoded by RLG1 and Ada5p,
causes unconventional splicing of HAC1 mRNA. HAC1
mRNA splicing allows efficient translation of Hac1p, which has a basic leucine zipper domain and functions as a transcriptional factor for
genes regulated by the UPR, such as KAR2, PDI1,
and FKB2. Since Hac1p is necessary for
IRE1-mediated KAR2 induction as a positive
transcription factor, mutants having a defect in ire1 or
hac1 are unable to induce the transcription of
KAR2, resulting in an inability of yeast cells to grow under
stress conditions such as with the addition of tunicamycin.
The IRE1 gene was first identified as the gene for inositol
prototrophy (Ino+) of S. cerevisiae (29), and the HAC1 gene
was isolated as a multicopy suppressor gene for the ire1
mutation (26). Mutants having a defect in ire1
or hac1 show inositol auxotrophy
(Ino
) due to an inability to fully induce the
expression of the INO1 gene, which encodes a rate-limiting
enzyme for inositol synthesis (4, 24, 26). In
S. cerevisiae, inositol is synthesized de novo in
cells through the conversion of glucose 6-phosphate to inositol
1-phosphate, followed by dephosphorylation (5). The former
reaction is mediated by inositol 1-phosphate synthase encoded by
INO1 (6). Inositol is also taken up into cells
in a carrier-mediated manner. S. cerevisiae
possesses two distinct inositol transport systems. The major transport
system is encoded by ITR1, and the minor one is encoded by
ITR2 (30, 31). It is known that the expression
of INO1 and ITR1, as well as a number of genes
for enzymes involved in the synthesis of phospholipids in S. cerevisiae, is repressed in cells grown in the presence of
inositol and derepressed in cells grown in the absence of inositol (32). INO1 and other coregulated genes of
phospholipid biosynthesis contain one or two stretches of a conserved
cis-acting promoter element, termed the
inositol-choline-responsive element (ICRE). The INO2 and
INO4 genes encode basic helix-loop-helix proteins that form
a heterodimer and function as a transcriptional factor through binding
to the ICRE (1, 41). Mutants having a defect in not only
ino1 but also ino2 or ino4 exhibit the
Ino
phenotype (10, 12). Several
other mutants also show the Ino
phenotype. For
example, mutations in the large subunit of RNA polymerase II
(40) and the TATA binding protein (2, 43) lead to the Ino
phenotype due to an inability
to express the INO1 gene. Depletion of the general
transcription factor TFIIA also impairs INO1 activation (21). Cells having defects in the SWI1,
SWI2, and SWI3 genes, which encode components of
the SWI-SNF chromatin-remodeling complex, exhibit a derepression defect
of INO1 (33-35). Furthermore, deletion of the
INO80 gene, which is an SNF2-SWI2 paralogue and
encodes a component of the INO80 chromatin-remodeling
complex, prevents the efficient expression of INO1 (7,
42). On the other hand, mutations in the SIN3 and
UME6 genes lead to high-level INO1 expression (15, 16). The SIN3 and UME6 gene
products are components of a large complex that contains the
RPD3 gene product, a histone deacetylase (17, 18,
39). Deletion of the RPD3 gene also leads to
high-level INO1 expression. Additionally, a mutation in the
OPI1 gene that encodes a protein containing leucine zipper and polyglutamine stretch motifs leads to an inositol overproduction phenotype (47).
Little is known about the mechanism by which defects of the
IRE1 or HAC1 gene lead to a decrease in
INO1 expression or about the mechanism by which inositol
regulates INO1 expression. In this study, we attempted to
isolate and characterize the yeast gene that can suppress the
Ino
phenotype of the
hac1 strain
when present in multiple copies. Here, we show that multiple copies of
truncated ITC1 can suppress the Ino
phenotype of the
ire1 and
hac1 strains and
that the Isw2p-Itc1p complex usually represses INO1 expression.
 |
MATERIALS AND METHODS |
Yeast strains and culture.
S.
cerevisiae strains D452-2 (MAT
leu2
his3 ura3), as the wild-type strain, YF4
(MAT
leu2 his3 ura3
ire1::URA3), and HU1 (MAT
leu2 his3 ura3
hac1::URA3) were described previously
(26). Yeast cells were cultured aerobically in either
yeast-peptone-dextrose or synthetic minimal medium with shaking
at 30°C. The compositions of the yeast-peptone-dextrose and
inositol-free minimal medium were as described previously
(48). Inositol was added to the minimal medium at a
concentration of 20 µg/ml. When necessary, L-leucine, L-histidine, and
uracil were each added to the culture media at 20 µg/ml. Tunicamycin
was added to the culture media at 0.5 µg/ml.
Plasmid construction.
YCp50 (38) and YCpL2
(22) are centromere-based vectors with the URA3
and LEU2 genes as selectable markers, respectively. YCpH2 is
a centromere-based vector with the HIS3 gene as a selectable marker and was constructed as follows. The 1.8-kbp BamHI
fragment of the HIS3 gene was inserted into the
BamHI site of pUC19 to yield pUC-HIS3. The 2.3-kbp
EcoRI/SmaI fragment of YCp50 was replaced with
the 1.8-kbp EcoRI/HincII fragment of pUC-HIS3 to
yield YCpH2. YEpM4 (28) and pHV-1 (37) are
2µm DNA-based vectors with the LEU2 and HIS3
genes as selectable markers, respectively. pADANS is a 2µm DNA-based
vector with the yeast ADH1 promoter, the following small
part of the coding region, the ADH1 terminator, and the yeast LEU2 gene (3). The LEU2 gene
of pADANS was replaced with the LEU2 gene of pGAD424
(Clontech). The LEU2 gene in pADANS
E thus obtained has no
EcoRI site. Plasmid pIR42, harboring HAC1, was
described previously (25). To construct a single-copy
plasmid carrying the HAC1 gene, pIR42 was digested with
BamHI and SmaI. An approximately 3.5-kbp fragment
containing the HAC1 gene was ligated between the
BamHI and SmaI sites of YCpL2 to yield YCpL2-42. Plasmid YEp133t containing a truncated form of ITC1 was
originally isolated from a yeast genomic library which was described
previously (28). To construct a multicopy plasmid carrying
a truncated form of PCL10, an approximately 1.8-kbp
HindIII/ScaI fragment from YEp133t was
ligated between the HindIII and ScaI sites of YEpM4 to yield YEpPCL10. To construct a single-copy plasmid containing the truncated form of ITC1, an approximately 4.2-kbp
BamHI/XbaI fragment from YEp133t was ligated
between the BamHI and XbaI sites of YCpL2 to
yield YCpL2-133t.
To construct a multicopy plasmid containing full-length
ITC1, ITC1 was amplified by PCR with chromosomal
DNA as a template. The PCR primers used were
5'-CAATGGTGTTATATAAAAGG-3' and
5'-GTATGGTCCAATCTTGCGCG-3'. An approximately 3.9-kbp PCR
product was inserted into vector pCR2.1-TOPO (Invitrogen) to yield
pTA-ITC1. pTA-ITC1 was digested with NcoI and
SacI, and an approximately 1.7-kbp fragment containing the
3' region of ITC1 was separated by electrophoresis. YEp133t was digested with NcoI and SacI and subjected to
electrophoresis to remove the small fragment, and then the fragment
containing the 3' region of ITC1 described above was
inserted between the NcoI and SacI sites of
YEp133t to yield YEp133w. The sequence of the 3' region of
ITC1 amplified by PCR was verified. To construct a
single-copy plasmid containing full-length ITC1, YEp133w was digested with BamHI and XbaI. An approximately
5.2-kbp fragment containing full-length ITC1 was ligated
between the BamHI and XbaI sites of YCpL2 to
yield YCpL2-133w. To construct a multicopy plasmid containing
ITC1 deletion derivatives, an approximately 3.6-kbp
HindIII/EcoRV fragment of YEp133w was
inserted between the HindIII and SmaI sites
of YEpM4 to yield YEp133
1. An approximately 3.9-kbp
HindIII fragment of YEp133w was inserted into the
HindIII site of YEpM4 to yield YEp133
2. To construct
single-copy plasmids containing the INO1-lacZ fusion gene,
YEpINO1Z (13) was digested with HindIII and
SmaI. An approximately 4-kbp
HindIII/SmaI fragment containing the
INO1-lacZ fusion gene was treated with Klenow large fragment
and then inserted into the SmaI sites of YCpH2 and YCpL2 to
yield YCpH2-INO1Z and YCpL2-INO1Z, respectively. To construct a
single-copy plasmid containing the ISW2 gene, pISW2w (see
below) was digested with SpeI. An approximately 6.1-kbp
fragment containing the ISW2 gene was inserted into the
XbaI site of YCpL2 to yield YCpL2-ISW2. To construct a
multicopy plasmid that expresses Isw2p under the control of the
ADH1 promoter, the ISW2 gene was amplified by PCR
with chromosomal DNA as a template. The PCR primers used were
5'-TCATGACAGCCCAGCAAG-3' and
5'-GCTTCTTGATCAATTTTG-3'. An approximately 3.3-kbp PCR
product was inserted into pCR2.1-TOPO to yield pTA-ISW2. pTA-ISW2 was
digested with SpeI and XhoI, and an approximately
3.3-kbp SpeI/XhoI fragment containing the
ISW2 gene was inserted between the SpeI and
XhoI sites of pBluescript II KS(+) to yield pKS+ISW2.
pKS+ISW2 was digested with NotI, and an approximately
3.3-kbp NotI fragment containing the ISW2 gene was inserted into the NotI site of pADANS
E to yield
pAD-ISW2. pAD-ISW2 was digested with BamHI, and an
approximately 5.3-kbp BamHI fragment containing the
ADH1-ISW2 fusion gene was inserted into the BamHI
site of pUC18 to yield pUC18-ISW2. An approximately 5.3-kbp
SalI/SmaI fragment of pUC18-ISW2 containing the
ADH1-ISW2 fusion gene was inserted between the
SalI and SmaI sites of pHV1 to yield pHV-ADISW2.
Isolation of the wild-type ISW2 gene.
For
isolation of the wild-type ISW2 gene, genomic DNA from
D452-2 was digested with BglII and XhoI, and then
approximately 8-kbp fragments were separated by gel electrophoresis and
inserted between the BamHI and XhoI sites of
pBluescript II KS(+). Escherichia coli cells were
transformed with the ligation mixture. A transformant harboring the
yeast ISW2-containing plasmid was detected by the PCR method
using the synthetic primers described above, and the plasmid pISW2w was
recovered from the transformant.
Construction of gene-disrupted strains.
To construct the
itc1,
isw2,
hac1
itc1, and
hac1
isw2 strains,
HIS3-disrupted ITC1 and HIS3-disrupted
ISW2 gene fragments were constructed by the method for the
synthesis of marker-disrupted alleles of yeast genes (27).
The PCR primers used for ITC1 disruption were
5'-CAATGGTGTTATATAAAAGG-3',
5'-GTGTCTCCTCACTATCCAG-3',
5'-CTGGTTAGATAATTGGGG-3', and
5'-CCTCGCGCCTGGCCTCTG-3'. The PCR primers used for
ISW2 disruption were 5'-TCATGACGACCCAGCAAG-3',
5'-GTACGTATCGGACTTGTC-3',
5'-GAGGCAGAAAATCGAACAG-3', and
5'-GCTTCTTGATCAATTTTG-3'. The HIS3-disrupted gene
fragments were used for the transformation of D452-2 and HU1.
His+ colonies were selected, and gene disruption
was confirmed by PCR with their chromosomal DNA as a template. The
itc1,
isw2,
hac1
itc1, and
hac1
isw2 strains
thus obtained were designated IH-1, SH-1, HIW, and HSW, respectively.
-Galactosidase assay.
-Galactosidase was assayed at
37°C by measuring the increase in the absorbance at 420 nm with
o-nitrophenyl-
-D-galactoside as the
substrate after cells had been permeabilized with chloroform and sodium
dodecyl sulfate as described previously (14).
Northern blot analysis.
For Northern blot analysis, total
RNA was isolated from yeast cells as described by Kataoka et al.
(19). Samples were subjected to electrophoresis in a 1%
agarose gel containing formaldehyde, blotted onto a Biodyne A membrane
(Pall BioSupport), and then hybridized. The probes used were
32P-labeled DNA fragments (with BcaBEST Labeling
Kit [Takara Biochemicals]) of the entire coding regions of
INO1 and ACT1, which were prepared by PCR.
Hybridization and detection were carried out according to the
manufacturer's manual.
Microscopic analysis.
To investigate cell morphology, cells
were grown to the early log phase in minimal medium containing
inositol. Images were taken under a confocal laser scanning microscope
(LSM510; Carl Zeiss).
 |
RESULTS |
Isolation of the suppressor gene.
Disruption of
IRE1 or HAC1 in S. cerevisiae results in the Ino
phenotype (4, 26). To elucidate the mechanism underlying the Ino
phenotype caused by ire1 or
hac1 disruption, we attempted to isolate yeast suppressor
genes that, when present in multiple copies, can suppress the
Ino
phenotype of the
hac1 strain.
The
hac1 strain, HU1, was transformed with a yeast
genomic library constructed on a multicopy vector, with transformants
that grew on inositol-free minimal medium being selected. Plasmids were
isolated from the independent transformants. After retransformation of
plasmids into yeast cells, four plasmids were found to be able to
complement the
hac1 strain. Restriction endonuclease
analysis and sequence analysis revealed that all four plasmids were
identical and contained 4.2-kbp inserts. We designated these plasmids
YEp133t and used them for further analysis. As shown in Fig.
1A, the insert fragment in plasmid
YEp133t was derived from chromosome VII and included two truncated open
reading frames (ORFs), PCL10 (YGL132w) and
ITC1 (YGL133w). However, the coding region of
PCL10 is incomplete and its promoter region is missing in
plasmid YEp133t. The subcloning study indicated that the
hac1 strain transformed with multicopy plasmid YEpPCL10
(Fig. 1A), which contains the 1.8-kbp
HindIII/ScaI fragment derived from the insert
fragment of YEp133t, exhibited the Ino
phenotype. Therefore, we concluded that ITC1 but not
PCL10 suppresses the Ino
phenotype
of the
hac1 strain. The ITC1 present in
plasmid YEp133t is the truncated form and lacks the 3' region of the
ORF. We designated this truncated gene ITC1
. Plasmid
YEp133t clearly suppressed the Ino
phenotype of
the
hac1 strain on inositol-free minimal medium (Fig.
1B). Overexpression of ITC1
also suppressed the
Ino
phenotype of the
ire1 strain.
However, overexpression of ITC1
could not restore the
tunicamycin sensitivity of the
ire1 and
hac1 strains (data not shown). To determine whether a
single copy of ITC1
could also suppress the
Ino
phenotype of the
ire1 and
hac1 strains, a CEN4-based plasmid harboring
ITC1
, YCpL2-133t, was constructed and introduced into the
ire1 and
hac1 strains. The transformants
obtained showed the Ino
phenotype, indicating
that the suppression of the Ino
phenotype of
the
ire1 and
hac1 strains is caused by the
gene dosage effect of ITC1
(data not shown).

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 1.
Cloning of the suppressor gene. (A) Restriction map of
the genomic region of S. cerevisiae
containing the suppressor gene. The size and transcriptional
orientation of each ORF are shown by arrows. Solid bars indicate the
inserts of originally isolated plasmid YEp133t and its subclone,
YEpPCL10. +, ability to complement the Ino phenotype of
the hac1 strain; , inability to complement it.
Abbreviations: E, EcoT22I; H, HindIII; N,
NcoI; S, ScaI; V, EcoRV.
(B) Suppression of the Ino phenotype of the
hac1 strain by ITC1 . The
hac1 strain, HU1, harboring YCpL2-42
(HAC1), YEp133t (ITC1 ), or vector
YEpM4 alone was streaked onto minimal medium containing histidine with
or without inositol. The transformants were grown at 30°C for 3 days.
|
|
Overexpression of full-length ITC1 in a
hac1 strain.
ITC1 encodes a protein
of 1,264 amino acid residues. The ITC1 product, Itc1p,
contains a nuclear localization signal and a leucine zipper domain, a
motif frequently found in DNA-binding proteins (8). The
originally isolated ITC1
encodes a truncated protein,
Itc1
p, which lacks 299 amino acids at the C-terminal end (Fig.
2A). We next examined whether full-length
ITC1 can suppress the Ino
phenotype
of the
hac1 strain. For this purpose, we constructed multicopy plasmid YEp133w carrying full-length ITC1 (see
Materials and Methods) and introduced it into the
hac1
strain, HU1. Interestingly, full-length ITC1 suppressed the
Ino
phenotype of the
hac1 strain
much more weakly than ITC1
(Fig. 2B). This revealed that
deletion of the C-terminal region of Itc1p is important for efficient
suppression of the Ino
phenotype of the
hac1 strain.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 2.
Deletion analysis of ITC1. (A) Linear
diagram of Itc1p with a schematic representation of the deletion
derivatives. The nuclear localization signal and leucine zipper domain
within Itc1p are shown as solid and hatched boxes, respectively. Amino
acid numbers from the initiation methionine are shown at the top. The
bars show the approximate sizes of the truncated forms of Itc1p, with
the number of amino acids (aa) at the right of each bar. (B)
Suppression of the Ino phenotype of the
hac1 strain by ITC1 deletion
derivatives. HU1 harboring YCpL2-42 (HAC1), YEp133 1
(ITC1 1), YEp133 2
(ITC1 2), YEp133t
(ITC1 ), YEp133w (ITC1), or vector
YEpM4 alone was 10-fold serially diluted and then spotted onto minimal
medium containing histidine with or without inositol. The transformants
were grown at 30°C for 3 days.
|
|
Deletion analysis of ITC1.
The C-terminal
region of Itc1p missing in Itc1
p does not contain any obvious amino
acid motif. To investigate the functional significance of the
C-terminal region of Itc1p in suppression of the
Ino
phenotype of the
hac1 strain,
we next constructed multicopy plasmids carrying a series of
ITC1 deletion derivatives (Fig. 2A). Plasmids YEp133
1 and
YEp133
2 carry ITC1
1 and
ITC1
2, respectively. ITC1
1 and ITC1
2
encode truncated proteins comprising amino acid residues 1 to 757 and 1 to 850, respectively. After transformation of these plasmids into the
hac1 strain, HU1, the transformants were examined for
their ability to suppress the Ino
phenotype of
this strain. As shown Fig. 2B, all the transformants grew at
approximately the same rate on inositol-containing medium. However, on
inositol-free medium, only the transformant having multiple copies of
ITC1
exhibited the Ino+ phenotype
similarly to the transformant having a single copy of HAC1.
In contrast, ITC1
1 and
ITC1
2 suppressed the
Ino
phenotype of the
hac1 strain
much more weakly than ITC1
did. This indicates that the
deletion of about 299 amino acids at the C-terminal end of Itc1p is
critical for suppression of the Ino
phenotype
of the
hac1 strain, but further deletion abolished the
ability of the suppression. Taken together, the above results suggest
that the C-terminal region of Itc1p has an inhibitory effect on
suppression of the Ino
phenotype of the
hac1 strain and that the function of Itc1p might be
regulated by its C-terminal region.
Effect of overexpression of ITC1
on
INO1 expression.
We next determined the effect of
multiple copies of ITC1
on INO1 expression
using the INO1-lacZ fusion gene as a reporter gene. Plasmid
YCpH2-INO1Z carrying the INO1-lacZ fusion gene was introduced into the
hac1 strain, HU1, together with a
single copy of HAC1, multiple copies of ITC1
,
or vector plasmid YEpM4. The transformants were grown in the absence of
inositol, and then
-galactosidase activity was measured (Fig.
3). Consistent with a previous report
(24), the level of
-galactosidase activity in the
hac1 strain containing the vector alone was lower than that observed in the
hac1 strain containing a single copy
of HAC1. In contrast, the level of
-galactosidase
activity in the
hac1 strain transformed with multiple
copies of ITC1
was higher than that observed in the
hac1 strain transformed with the vector alone. These
results indicate that the overexpression of ITC1
induces
the transcriptional upregulation of INO1. This is why the
hac1 strain transformed with YEp133t shows the
Ino+ phenotype.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of ITC1 on INO1
expression. The hac1 strain harboring YCpH2-INO1Z
carrying the INO1-lacZ fusion gene together with
YCpL2-42 (HAC1), YEp133t (ITC1 ), or
vector YEpM4 was precultured in minimal medium containing inositol for
12 h. The cells were then washed twice with water and cultured
further in fresh minimal medium without inositol. At the indicated
times, cells were removed from the cultures and -galactosidase
activity was measured. Data are means of three independent
transformants. Error bars indicate standard deviations.
|
|
Phenotype of the
hac1
itc1
strain.
We next determined the effect of the deletion of
ITC1 on cell growth. We first constructed a
itc1 strain, IH-1, and its phenotype was examined. The
itc1 strain did not show the Ino
phenotype and, as reported previously (8), exhibited
aberrant morphology (see below). We next constructed a
hac1
itc1 strain, HIW. The
hac1
itc1 strain also exhibited aberrant
morphology (data not shown). Surprisingly, the
hac1
itc1 strain did not show the Ino
phenotype (Fig. 4A). To confirm this, a
single copy of ITC1 on a CEN4-based vector was
introduced into the
hac1
itc1 strain and
then its phenotype was examined. The transformants clearly exhibited
the Ino
phenotype, similar to the
hac1 strain (Fig. 4A). This indicates that the deletion
of ITC1 can suppress the Ino
phenotype of the
hac1 strain, suggesting that Itc1p is a
negative regulator for the expression of INO1. However, the
hac1
itc1 strain carrying a single copy of
ITC1
did not exhibit the Ino
phenotype (Fig. 4A), suggesting that only full-length ITC1
can function as a negative regulator for the expression of
INO1.

View larger version (70K):
[in this window]
[in a new window]
|
FIG. 4.
Phenotypes of the hac1
itc1 and hac1
isw2 strains. (A) Ino+ phenotype of the
hac1 itc1 strain. The
hac1 itc1 strain, HIW, harboring
YCpL2-42 (HAC1), YCpL2-133t (ITC1 ),
YCpL2-133w (ITC1), or vector YCpL2 alone was grown on
minimal medium with or without inositol at 30°C for 3 days. (B)
Ino+ phenotype of the hac1
isw2 strain. The hac1
isw2 strain, HSW, harboring YCpL2-42
(HAC1), YCpL2-ISW2 (ISW2), or vector
YCpL2 alone was grown on minimal medium with or without inositol at
30°C for 3 days. In both panels, the hac1 strain,
HU1, harboring vector YCpH2 together with YCpL2-42 or vector YCpL2 is
also shown, indicated by hac1 (HAC1)
and hac1 (vector), respectively.
|
|
Phenotype of the
hac1
isw2
strain.
Recently, it was reported that Itc1p, together with a gene
product of ISW2 (45), constitutes a
chromatin-remodeling complex (http://genome-www.stanford.edu/Saccharomyces/). Therefore, we next
determined the effect of Isw2p on the expression of INO1. For this purpose, we constructed a
hac1
isw2 strain, HSW. This strain exhibited aberrant
morphology, similar to that of the
hac1
itc1 strain (data not shown), and also exhibited the
Ino+ phenotype. To confirm this more exactly, the
hac1
isw2 strain was transformed with a
single copy of HAC1, a single copy of ISW2, or
vector plasmid YCpL2. The transformants were grown on minimal medium
with or without inositol, and then the phenotype was examined (Fig.
4B). The
hac1
isw2 strain carrying the
vector alone exhibited the Ino+ phenotype. In
contrast, the Ino
phenotype reappeared when a
single copy of ISW2 was introduced into the
hac1
isw2 strain. This clearly suggests
that Itc1p, together with Isw2p, functions as a negative regulator of
INO1. It should be noted that the
isw2 strain
we constructed also exhibited the Ino+ phenotype
and aberrant morphology, similar to the
itc1 strain (see below).
The Isw2p-Itc1p complex represses INO1
expression.
The data presented above strongly suggest that the
Isw2p-Itc1p chromatin-remodeling complex represses the expression of
INO1. To examine this possibility further, we introduced
single-copy plasmid YCpL2-INO1Z carrying the INO1-lacZ
fusion gene into strains HU1 (
hac1), IH-1
(
itc1), HIW (
hac1
itc1), SH-1
(
isw2), HSW (
hac1
isw2), and
D452-2 (wild type). The transformants were cultured in
inositol-containing minimal medium, and then
-galactosidase activity
was measured. As shown in Fig. 5A, the
wild-type and
hac1 cells exhibited low levels of
-galactosidase activity, indicating that the expression of
INO1 is repressed by inositol in the medium. In contrast,
the levels of
-galactosidase activity in the
itc1,
hac1
itc1,
isw2, and
hac1
isw2 cells were much higher than those
observed in the wild-type and
hac1 cells, strongly suggesting that the expression of INO1 is derepressed in
these cells even in the presence of inositol in the medium. To confirm this, we next determined the abundance of mRNA of INO1 in
disruptants by Northern blot analysis. The wild-type,
hac1,
itc1,
hac1
itc1,
isw2, and
hac1
isw2 strains were grown to the early log phase in minimal
medium containing inositol and then subjected to analysis (Fig. 5B).
Consistent with the results obtained for the INO1-lacZ
fusion gene, the amount of INO1 mRNA was low in the
wild-type and
hac1 cells, whereas the
itc1,
hac1
itc1,
isw2, and
hac1
isw2 cells showed high levels of
INO1 mRNA. These data indicate that the Isw2p-Itc1p
chromatin-remodeling complex represses the INO1 expression
in the wild-type and
hac1 cells, and the disruption of
either ITC1 or ISW2 abolishes the function of the
chromatin-remodeling complex, resulting in derepression of the
INO1 expression. This is why the
hac1
itc1 and
hac1
isw2 strains
can grow on inositol-free medium.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 5.
INO1 expression in itc1,
isw2, hac1 itc1,
and hac1 isw2 strains. (A) Reporter
gene analysis of INO1 expression. Strains D452-2 (WT),
HU1 ( hac1), IH-1 ( itc1), HIW
( hac1 itc1), SH-1
( isw2), and HSW ( hac1
isw2) were transformed with YCpL2-INO1Z carrying the
INO1-lacZ fusion gene. The transformants were
precultured in minimal medium containing inositol for 12 h. The
cells were then washed twice with water and cultured further in fresh
minimal medium containing inositol. After the cells had reached the
early log phase, -galactosidase activity was measured. Data are
means for four independent transformants. Error bars indicate standard
deviations. (B) Northern blot analysis of INO1 mRNA.
Strains D452-2 (WT), HU1 ( hac1), IH-1
( itc1), HIW ( hac1
itc1), SH-1 ( isw2), and HSW
( hac1 isw2) were grown to the early
log phase in minimal medium with inositol. Total RNA was isolated and
used for Northern blot analysis (25 µg per lane).
|
|
Effects of overexpression of ITC1
and
ISW2 on the Ino
phenotype.
We next
determined the effects of overexpression of ITC1 and
ISW2 on the Ino
phenotype of the
hac1 strain. The
hac1 strain was
transformed with multiple copies of ISW2, multiple copies of
ITC1
, or both. In the case of multiple copies of
ISW2, we used a construct in which the expression of
ISW2 is under the control of the ADH1 promoter.
The transformants were grown on minimal medium with or without inositol
(Fig. 6). As shown above, growth of the
hac1 strain carrying multiple copies of
ITC1
was similar to that of the strain having the
HAC1 gene. However, the
hac1 strain carrying multiple copies of both ISW2 and ITC1
showed
the Ino
phenotype, similar to the
hac1 strain carrying vectors. Furthermore, the
introduction of multiple copies of ISW2 into the
hac1 strain resulted in a stronger
Ino
phenotype, suggesting that the
overexpression of ISW2 causes severe repression of
INO1. On the other hand, introduction of multiple copies of
ITC1 had little effect on the Ino
phenotype of the
hac1 strain, as described above.
Multiple copies of ITC1, whose expression is under the
control of the ADH1 promoter, also had little effect (data
not shown). It seems likely that the activity of the Isw2p-Itc1p
complex is regulated by the amount of Isw2p.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 6.
Effects of overexpression of ITC1 and
ISW2 on INO1 expression. The
hac1 strain, HU1, harboring pHV-ADISW2 plus vector
YEpM4 (ISW2), vector pHV-1 plus YEp133t
(ITC1 ), pHV-ADISW2 plus YEp133t
(ISW2-ITC1 ), vector pHV-1 plus
YCpL2-42 (HAC1), or vector pHV-1 plus vector YEpM4
(vector) was 10-fold serially diluted and then spotted onto minimal
medium with or without inositol. The transformants were grown at 30°C
for 3 days.
|
|
Aberrant morphology of the
itc1 and
isw2 strains.
It has been reported that the
deletion of ITC1 in
-type cells causes aberrant
morphology resembling that of cells exposed to mating factors. This
phenotype is not observed for MATa cells
(8). This aberrant morphology is confirmed by the data shown in Fig. 7. Furthermore, we also
found that the
isw2 strain shows a similar aberrant
morphology. We confirmed that a single copy of ISW2 could
reverse the aberrant morphology of the
isw2 strain. This
strongly suggests that the Isw2p-Itc1p chromatin-remodeling complex
plays a critical role in maintenance of the morphology of cells. We
next examined the effect of the truncated form of ITC1 on
cell morphology. The
itc1 strain, IH-1, was transformed with a series of ITC1 deletion derivatives constructed on a
multicopy plasmid (Fig. 2), and the cell morphology of the
transformants was observed. As shown in Fig. 7, the
itc1
and
isw2 cells exhibited aberrant morphology (29 and
26%, respectively). A small number of the
itc1 cells
exhibited the aberrant morphology when transformed with full-length
ITC1 (3%). On the other hand, the transformants of
ITC1
1 and ITC1
each included a
moderate number of the aberrant cells (14 and 6%, respectively). It
seems likely that the C-terminal region of Itc1p is critical for the
repression of INO1 but not for maintenance of morphology.

View larger version (87K):
[in this window]
[in a new window]
|
FIG. 7.
Aberrant morphology of itc1 and
isw2 strains. The itc1 strain,
IH-1, transformed with either YEp133 1
(ITC1 1), YEp133t
(ITC1 ), YEp133w (ITC1), or vector
YEpM4 alone and strains D452-2 (WT) and SH-1 ( isw2)
were grown to the early log phase in minimal medium with inositol. Cell
morphology was observed microscopically. Values in parentheses are
percentages of morphologically aberrant cells determined under a
microscope.
|
|
 |
DISCUSSION |
In this study, we isolated a truncated form of ITC1,
ITC1
, as a suppressor gene for the
Ino
phenotype of the
hac1 strain.
From the results of the reporter gene assay (Fig. 3), multiple copies
of ITC1
were found to be able to derepress
INO1 expression and circumvent the inositol requirement for
growth of the
hac1 strain (Fig. 2B). However, overexpression of the full-length ITC1 had a moderate effect
on the growth of the
hac1 strain. ITC1 encodes
a protein of 1,264 amino acids which is a component of the
chromatin-remodeling complex (45). The gene product of
ITC1
we obtained lacks 299 amino acids at the C-terminal
end. The truncated form further truncated at the C terminus
suppressed the Ino
phenotype of the
hac1 strain more weakly than ITC1
,
suggesting that the length of the C-terminal region of Itc1p is
critical for the derepression of INO1 expression.
Furthermore, deletion of the chromosomal ITC1 gene in the
hac1 strain also suppressed the
Ino
phenotype of the
hac1 strain
(Fig. 4A). Introduction of a single copy of ITC1 into the
hac1
itc1 strain gave it the
Ino
phenotype again, but ITC1
did
not. These results indicate that Itc1p is a negative regulator for
INO1 expression and that the truncated form of Itc1p,
Itc1
p, competes with the effect of full-length Itc1p.
Itc1p and Isw2p form a chromatin-remodeling complex (45).
This complex possesses nucleosome-stimulated ATPase and ATP-dependent nucleosome spacing activities. Isw2p exhibits ATPase activity. Therefore, we predicted that the disruption of ISW2 could
also derepress the expression of INO1 and suppress the
Ino
phenotype of the
hac1 strain,
and we found that this is the case. As shown in this study, deletion of
not only ITC1 but also ISW2 in the wild-type and
hac1 strains caused the derepression of INO1
expression even in the presence of inositol in the culture medium (Fig.
5). Inositol is well known to repress the expression of
INO1. The
hac1
isw2 strain can
grow on inositol-free minimal medium (Fig. 4B). Conversely,
introduction of multiple copies of ISW2, whose expression is
under the control of the ADH1 promoter, into the
hac1 strain caused a severer Ino
phenotype. Multiple copies of ITC1 of similar construction
had no effect (data not shown). These results indicate that the amount of Isw2p limits the formation of the Isw2p-Itc1p complex.
During the preparation of this paper, data showing that the Isw2p-Itc1p
chromatin-remodeling complex represses the expression of
INO1 were reported by Goldmark et al. (9). By
determining the levels of INO1 mRNA, they showed that the
expression of INO1 is partially derepressed in the
isw2 strain. They also revealed that the Isw2p-Itc1p
chromatin-remodeling complex represses early meiotic genes during
mitotic growth in a pathway parallel to that of the Rpd3p-Sin3p histone
deacetylase complex and that the repressor function of the Isw2p-Itc1p
complex is largely dependent on Ume6p, a sequence-specific DNA-binding
protein. Their findings that the Isw2p-Itc1p chromatin-remodeling
complex represses INO1 expression and that the disruption of
ISW2 abolishes the function of the remodeling complex are
consistent with the results we obtained in this study.
Taken together, these results suggest that the Isw2p-Itc1p
chromatin-remodeling complex usually represses INO1
expression (Fig. 8). The amount of Isw2p
is limited. Overexpression of ITC1
leads to the
accumulation of the truncated form of Itc1p, Itc1
p. Hence, a large
amount of Itc1
p deprives the Isw2-Itc1p chromatin-remodeling complex
of Isw2p, resulting in derepression of the INO1 expression. In this model, it is strongly suggested that the C-terminal region of
Itc1p has a regulatory effect on the Itc1p function. Itc1
p behaves
in a dominant negative manner toward Itc1p. Consistent with this idea,
Goldmark et al. noticed that there are two types of Itc1p in yeast
cells and that the electrophoretically slow-migrating one
preferentially interacts with Ume6p. These two species might be
generated through modification of the C-terminal region of Itc1p. The
truncated form of Itc1p encoded by ITC1
that we obtained might have no ability to bind to Ume6p, so the chromatin-remodeling function was lost. According to their data, the derepression of INO1 caused by the deletion of ISW2 is moderate
compared to that caused by the deletion of RPD3,
SIN3, or UME6 (2.8-, 17-, 48-, and 117-fold,
respectively). As described above, we showed that the disruption of not
only ISW2 but also ITC1 restores the cell growth
of the
hac1 strain, which otherwise cannot grow on
inositol-free medium. Therefore, our data clearly suggest that a
decrease in the activity of the Isw2p-Itc1p chromatin-remodeling
complex is sufficient to overcome the Ino
phenotype caused by the defect of
IRE1-HAC1-mediated signaling. It is conceivable
that the level of INO1 expression is positively and
negatively regulated through the
IRE1-HAC1-mediated activation pathway and the
Isw2p-Itc1p complex-mediated repression pathway, respectively. However,
the relationship between these positive and negative pathways is still
unknown. The expression of the INO1 gene is known to be
facilitated by the SWI-SNF and ADA-GCN5 complexes (35,
36). The gene product of IRE1 interacts with some
component of the ADA-GCN5 complex and thereby regulates the function of
HAC1 (20, 46). But so far, the mechanisms by
which these complexes regulate the INO1 expression have not
been elucidated precisely.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 8.
Model of Itc1 p-mediated INO1
derepression. The Isw2p-Itc1p chromatin-remodeling complex represses
the expression of INO1. However, overexpression of
Itc1 p causes depletion of the active form of Isw2p from the
Isw2p-Itc1p complex responsible for the INO1 repression,
resulting in derepression of INO1. Although the
Isw2p-Itc1 p complex cannot repress the INO1
expression, the Isw2p-Itc1p chromatin-remodeling complex with
additionally overexpressed Isw2p restores the INO1
repression. In this model, the C-terminal region of Itc1p plays a
crucial role in the INO1 repression.
|
|
It has been reported that
itc1 cells show aberrant
morphology (8). We also found that the deletion of
ISW2 results in morphologic changes similar to those
observed in the
itc1 strain (Fig. 7). This clearly
suggests that the Isw2p-Itc1p complex is responsible for maintaining
the normal morphology of yeast cells. It has been reported that
ino2 cells exhibit aberrant morphology, similar to
itc1 and
isw2 cells (11). The
expression of INO2 is known to be regulated similarly to
that of INO1. The Isw2p-Itc1p complex might regulate
INO2 expression and maintain the morphology of the yeast
cells via Ino2p. Judging from the results obtained here with the
ITC1 deletion derivatives, the morphologic abnormality was
reversed upon the introduction of a series of the ITC1 gene, depending upon its length. However, in contrast to the effect on the
INO1 expression, the overexpression of ITC1
,
and even ITC1
1, partially but moderately
suppressed the aberrant morphology of the
itc1 strain.
This suggests that the mechanism for the suppression of the aberrant
morphology is different from that for the suppression of
INO1 expression and that the regulatory function of the
C-terminal region of Itc1p is different in these two forms of
suppression. As described above, early meiotic genes are known to be
derepressed in the
isw2 strain during mitotic growth.
However, the relationship between the mating type-specific morphologic
change observed here and the derepression of early meiotic genes is unknown.
We show here that the expression of INO1 in
isw2 or
itc1 strains is partially
derepressed even in the presence of inositol in the culture medium.
Preliminary experiments revealed that the level of derepression
increases further when inositol is removed from the culture medium.
These results indicate that the repression of INO1 by
inositol is partly mediated through the Isw2p-Itc1p chromatin-remodeling complex but that there could still be a sensory machinery for detecting the level of inositol and for regulating the
expression of genes which are regulated by inositol via the ICRE. To
elucidate the nature of this machinery and the functions of the Hac1p,
further detailed analyses with mutants of ISW2 and ITC1 are necessary.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemical Engineering and Science, Faculty of Computer Science and Systems Engineering, Kyushu Institute of Technology, Iizuka, Fukuoka 820-8502, Japan. Phone: 81-948-29-7822. Fax: 81-948-29-7801. E-mail: nikawa{at}bse.kyutech.ac.jp.
 |
REFERENCES |
| 1.
|
Ambroziak, J., and S. A. Henry.
1994.
INO2 and INO4 gene products, positive regulators of phospholipid biosynthesis in Saccharomyces cerevisiae, form a complex that binds to the INO1 promoter.
J. Biol. Chem.
269:15344-15349[Abstract/Free Full Text].
|
| 2.
|
Arndt, K. M.,
S. Ricupero-Hovasse, and F. Winston.
1995.
TBP mutants defective in activated transcription in vivo.
EMBO J.
14:1490-1497[Medline].
|
| 3.
|
Colicelli, J.,
C. Nicolette,
C. Birchmeier,
L. Rodgers,
M. Riggs, and M. Wigler.
1991.
Expression of three mammalian cDNAs that interfere with RAS function in Saccharomyces cerevisiae.
Proc. Natl. Acad. Sci. USA
88:2913-2917[Abstract/Free Full Text].
|
| 4.
|
Cox, J. S.,
R. E. Chapman, and P. Walter.
1997.
The unfolded protein response coordinates the production of endoplasmic reticulum protein and endoplasmic reticulum membrane.
Mol. Biol. Cell
8:1805-1814[Abstract].
|
| 5.
|
Culbertson, M. R.,
T. F. Donahue, and S. A. Henry.
1976.
Control of inositol biosynthesis in Saccharomyces cerevisiae: properties of a repressible enzyme system in extracts of wild-type (Ino+) cells.
J. Bacteriol.
126:232-242[Abstract/Free Full Text].
|
| 6.
|
Dean-Johnson, M., and S. Henry.
1989.
Biosynthesis of inositol in yeast: primary structure of myo-inositol-1-phosphate synthase (EC 5.5.1.4) and functional analysis of its structural gene, the INO1 locus.
J. Biol. Chem.
264:1274-1283[Abstract/Free Full Text].
|
| 7.
|
Ebbert, R.,
A. Birkmann, and H.-J. Schüller.
1999.
The product of the SNF2/SWI2 paralogue INO80 of Saccharomyces cerevisiae required for efficient expression of various yeast structural genes is part of a high-molecular-weight protein complex.
Mol. Microbiol.
32:741-751[CrossRef][Medline].
|
| 8.
|
Escribano, M. V., and M. J. Mazón.
2000.
Disruption of six novel ORFs from Saccharomyces cerevisiae chromosome VII and phenotypic analysis of the deletants.
Yeast
16:621-630[CrossRef][Medline].
|
| 9.
|
Goldmark, J. P.,
T. G. Fazzio,
P. W. Estep,
G. M. Church, and T. Tsukiyama.
2000.
The ISW2 chromatin remodeling complex represses early meiotic genes upon recruitment by Ume6p.
Cell
103:423-433[CrossRef][Medline].
|
| 10.
|
Greenberg, M. L., and J. M. Lopes.
1996.
Genetic regulation of phospholipid biosynthesis in Saccharomyces cerevisiae.
Microbiol. Rev.
60:1-20[Free Full Text].
|
| 11.
|
Hammond, C. I.,
P. Romano,
S. Roe, and P. Tontonoz.
1993.
INO2, a regulatory gene in yeast phospholipid biosynthesis, affects nuclear segregation and bud pattern formation.
Cell. Mol. Biol. Res.
39:561-577[Medline].
|
| 12.
|
Henry, S. A., and J. L. Patton-Vogt.
1998.
Genetic regulation of phospholipid metabolism: yeast as a model eukaryote.
Prog. Nucleic Acid Res. Mol. Biol.
61:133-179[Medline].
|
| 13.
|
Hosaka, K.,
J. Nikawa,
T. Kodaki, and S. Yamashita.
1992.
A dominant mutation that alters the regulation of INO1 expression in Saccharomyces cerevisiae.
J. Biochem.
111:352-358[Abstract/Free Full Text].
|
| 14.
|
Hosaka, K.,
T. Murakami,
T. Kodaki,
J. Nikawa, and S. Yamashita.
1990.
Repression of choline kinase by inositol and choline in Saccharomyces cerevisiae.
J. Bacteriol.
172:2005-2012[Abstract/Free Full Text].
|
| 15.
|
Hudak, K. A.,
J. M. Lopes, and S. A. Henry.
1994.
A pleiotropic phospholipid biosynthetic regulatory mutation in Saccharomyces cerevisiae is allelic to sin3 (sdi1, ume4, rpd1).
Genetics
136:475-483[Abstract].
|
| 16.
|
Jackson, J. C., and J. M. Lopes.
1996.
The yeast UME6 gene is required for both negative and positive transcriptional regulation of phospholipid biosynthetic gene expression.
Nucleic Acids Res.
24:1322-1329[Abstract/Free Full Text].
|
| 17.
|
Kadosh, D., and K. Struhl.
1998.
Targeted recruitment of the Sin3-Rpd3 histone deacetylase complex generates a highly localized domain of repressed chromatin in vivo.
Mol. Cell. Biol.
18:5121-5127[Abstract/Free Full Text].
|
| 18.
|
Kasten, M. M.,
S. Dorland, and D. J. Stillman.
1997.
A large protein complex containing the yeast Sin3p and Rpd3p transcriptional regulators.
Mol. Cell. Biol.
17:4852-4858[Abstract].
|
| 19.
|
Kataoka, T.,
D. Broek, and M. Wigler.
1985.
DNA sequence and characterization of the S. cerevisiae gene encoding adenylate cyclase.
Cell
43:493-505[CrossRef][Medline].
|
| 20.
|
Kaufman, R. J.
1999.
Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls.
Genes Dev.
13:1211-1233[Free Full Text].
|
| 21.
|
Liu, Q.,
S. E. Gabriel,
K. L. Roinick,
R. D. Ward, and K. M. Arndt.
1999.
Analysis of TFIIA function in vivo: evidence for a role in TATA-binding protein recruitment and gene-specific activation.
Mol. Cell. Biol.
19:8673-8685[Abstract/Free Full Text].
|
| 22.
|
Matsushita, M., and J. Nikawa.
1995.
Isolation and characterization of a SCT1 gene which can suppress a choline-transport mutant of Saccharomyces cerevisiae.
J. Biochem.
117:447-451[Abstract/Free Full Text].
|
| 23.
|
Mori, K.
2000.
Tripartite management of unfolded proteins in the endoplasmic reticulum.
Cell
101:451-454[CrossRef][Medline].
|
| 24.
|
Nikawa, J.
1994.
A cDNA encoding the human transforming growth factor receptor suppresses the growth defect of a yeast mutant.
Gene
149:367-372[CrossRef][Medline].
|
| 25.
|
Nikawa, J.,
A. Murakami,
E. Esumi, and K. Hosaka.
1995.
Cloning and sequence of the SCS2 gene, which can suppress the defect of INO1 expression in an inositol auxotrophic mutant of Saccharomyces cerevisiae.
J. Biochem.
118:39-45[Abstract/Free Full Text].
|
| 26.
|
Nikawa, J.,
M. Akiyoshi,
S. Hirata, and T. Fukuda.
1996.
Saccharomyces cerevisiae IRE2/HAC1 is involved in IRE1-mediated KAR2 expression.
Nucleic Acids Res.
24:4222-4226[Abstract/Free Full Text].
|
| 27.
|
Nikawa, J., and M. Kawabata.
1998.
PCR- and ligation-mediated synthesis of marker cassettes with long flanking homology regions for gene disruption in Saccharomyces cerevisiae.
Nucleic Acids Res.
26:860-861[Abstract/Free Full Text].
|
| 28.
|
Nikawa, J.,
P. Sass, and M. Wigler.
1987.
Cloning and characterization of the low-affinity cyclic AMP phosphodiesterase gene of Saccharomyces cerevisiae.
Mol. Cell. Biol.
7:3629-3636[Abstract/Free Full Text].
|
| 29.
|
Nikawa, J., and S. Yamashita.
1992.
IRE1 encodes a putative protein kinase containing a membrane-spanning domain and is required for inositol prototrophy in Saccharomyces cerevisiae.
Mol. Microbiol.
6:1441-1446[Medline].
|
| 30.
|
Nikawa, J.,
T. Nagumo, and S. Yamashita.
1982.
myo-Inositol transport in Saccharomyces cerevisiae.
J. Bacteriol.
150:441-446[Abstract/Free Full Text].
|
| 31.
|
Nikawa, J.,
Y. Tsukagoshi, and S. Yamashita.
1991.
Isolation and characterization of two distinct myo-inositol transport genes of Saccharomyces cerevisiae.
J. Biol. Chem.
266:11184-11191[Abstract/Free Full Text].
|
| 32.
|
Paltauf, F.,
S. D. Kohlwein, and S. A. Henry.
1992.
Regulation and compartmentalization of lipid synthesis in yeast, p. 415-500.
In
E. W. Jones, J. R. Pringle, and J. R. Broach (ed.), The molecular and cellular biology of the yeast Saccharomyces, vol. 2. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 33.
|
Peterson, C. L.,
A. Dingwall, and M. P. Scott.
1994.
Five SWI/SNF gene products are components of a large multisubunit complex required for transcriptional enhancement.
Proc. Natl. Acad. Sci. USA
91:2905-2908[Abstract/Free Full Text].
|
| 34.
|
Peterson, C. L., and I. Herskowitz.
1992.
Characterization of the yeast SWI1, SWI2, and SWI3 genes, which encode a global activator of transcription.
Cell
68:573-583[CrossRef][Medline].
|
| 35.
|
Peterson, C. L.,
W. Kruger, and I. Herskowitz.
1991.
A functional interaction between the C-terminal domain of RNA polymerase II and the negative regulator SIN1.
Cell
64:1135-1143[CrossRef][Medline].
|
| 36.
|
Pollard, K. J., and C. L. Peterson.
1997.
Role for ADA/GCN5 products in antagonizing chromatin-mediated transcriptional repression.
Mol. Cell. Biol.
17:6212-6222[Abstract].
|
| 37.
|
Rose, M. D., and J. R. Broach.
1991.
Cloning genes by complementation in yeast.
Methods Enzymol.
194:195-230[Medline].
|
| 38.
|
Rose, M. D.,
P. Novick,
J. H. Thomas,
D. Botstein, and G. R. Fink.
1987.
A Saccharomyces cerevisiae genomic plasmid bank based on a centromere-containing shuttle vector.
Gene
60:237-243[CrossRef][Medline].
|
| 39.
|
Rundlett, S. E.,
A. A. Carmen,
N. Suka,
B. M. Turner, and M. Grunstein.
1998.
Transcriptional repression by UME6 involves deacetylation of lysine 5 of histone H4 by RPD3.
Nature
392:831-835[CrossRef][Medline].
|
| 40.
|
Scafe, C.,
D. Chao,
J. Lopes,
J. P. Hirsch,
S. Henry, and R. A. Young.
1990.
RNA polymerase II C-terminal repeat influences response to transcriptional enhancer signals.
Nature
347:491-494[CrossRef][Medline].
|
| 41.
|
Schwank, S.,
R. Ebbert,
K. Rautenstrau ,
E. Schweizer, and H.-J. Schüller.
1995.
Yeast transcriptional activator INO2 interacts as an Ino2p/Ino4p basic helix-loop-helix heteromeric complex with the inositol/choline-responsive element necessary for expression of phospholipid biosynthetic genes in Saccharomyces cerevisiae.
Nucleic Acids Res.
23:230-237[Abstract/Free Full Text].
|
| 42.
|
Shen, X.,
G. Mizuguchi,
A. Hamiche, and C. Wu.
2000.
A chromatin remodelling complex involved in transcription and DNA processing.
Nature
406:541-544[CrossRef][Medline].
|
| 43.
|
Shirra, M. K., and K. M. Arndt.
1999.
Evidence for the involvement of the Glc7-Reg1 phosphatase and the Snf1-Snf4 kinase in the regulation of INO1 transcription in Saccharomyces cerevisiae.
Genetics
152:73-87[Abstract/Free Full Text].
|
| 44.
|
Sidrauski, C.,
R. Chapman, and P. Walter.
1998.
The unfolded protein response: an intracellular signalling pathway with many surprising features.
Trends Cell Biol.
8:245-249[CrossRef][Medline].
|
| 45.
|
Tsukiyama, T.,
J. Palmer,
C. C. Landel,
J. Shiloach, and C. Wu.
1999.
Characterization of the imitation switch subfamily of ATP-dependent chromatin-remodeling factors in Saccharomyces cerevisiae.
Genes Dev.
13:686-697[Abstract/Free Full Text].
|
| 46.
|
Welihinda, A. A.,
W. Tirasophon, and R. J. Kaufman.
2000.
The transcriptional co-activator ADA5 is required for HAC1 mRNA processing in vivo.
J. Biol. Chem.
275:3377-3381[Abstract/Free Full Text].
|
| 47.
|
White, M. J.,
J. P. Hirsch, and S. A. Henry.
1991.
The OPI1 gene of Saccharomyces cerevisiae, a negative regulator of phospholipid biosynthesis, encodes a protein containing polyglutamine tracts and a leucine zipper.
J. Biol. Chem.
266:863-872[Abstract/Free Full Text].
|
| 48.
|
Yamashita, S., and A. Oshima.
1980.
Regulation of phosphatidylethanolamine methyltransferase level by myo-inositol in Saccharomyces cerevisiae.
Eur. J. Biochem.
104:611-616[Medline].
|
Journal of Bacteriology, September 2001, p. 4985-4993, Vol. 183, No. 17
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.17.4985-4993.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Frydlova, I., Malcova, I., Vasicova, P., Hasek, J.
(2009). Deregulation of DSE1 Gene Expression Results in Aberrant Budding within the Birth Scar and Cell Wall Integrity Pathway Activation in Saccharomyces cerevisiae. Eukaryot Cell
8: 586-594
[Abstract]
[Full Text]
-
Dai, Z., Mao, X., Magnuson, J. K., Lasure, L. L.
(2004). Identification of Genes Associated with Morphology in Aspergillus niger by Using Suppression Subtractive Hybridization. Appl. Environ. Microbiol.
70: 2474-2485
[Abstract]
[Full Text]
-
McConnell, A. D., Gelbart, M. E., Tsukiyama, T.
(2004). Histone Fold Protein Dls1p Is Required for Isw2-Dependent Chromatin Remodeling In Vivo. Mol. Cell. Biol.
24: 2605-2613
[Abstract]
[Full Text]
-
Iida, T., Araki, H.
(2004). Noncompetitive Counteractions of DNA Polymerase {varepsilon} and ISW2/yCHRAC for Epigenetic Inheritance of Telomere Position Effect in Saccharomyces cerevisiae. Mol. Cell. Biol.
24: 217-227
[Abstract]
[Full Text]
-
Lee, K., Neigeborn, L., Kaufman, R. J.
(2003). The Unfolded Protein Response Is Required for Haploid Tolerance in Yeast. J. Biol. Chem.
278: 11818-11827
[Abstract]
[Full Text]
-
Ruiz, C., Escribano, V., Morgado, E., Molina, M., Mazon, M. J.
(2003). Cell-type-dependent repression of yeast a-specific genes requires Itc1p, a subunit of the Isw2p-Itc1p chromatin remodelling complex. Microbiology
149: 341-351
[Abstract]
[Full Text]